Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
Home arrow Investors arrow Proxy Materials

Proxy Materials

Transcept in the News

08/09/10
Transcept Pharmaceuticals Reports Second Quarter 2010 Financial Results

07/27/10
Transcept Pharmaceuticals to Report Second Quarter 2010 Results and Host Conference Call on August 9, 2010


PDF 2010 Proxy Statement
PDF 2010 Proxy Card
PDF Form 10-K - December 31, 2009
PDF Driving Instructions to Annual Meeting, June 2, 2010

 
Copyright © 2010  |